 |
|
Using Trade Names
A Risk Factor for Accidental Drug Overdose
Matthias Schwab, MD;
Carsten Oetzel, MD;
Klaus Mörike, MD;
Christine Jägle, MD;
Christoph H. Gleiter, MD;
Michel Eichelbaum, MD
Arch Intern Med. 2002;162:1065-1066.
Medication errors due to the exclusive use of trade names of drugs may
lead to life-threatening complications. We report the case of a patient with
verapamil overdose as a result of this. This case illustrates that the use
of trade names, omitting the international nonproprietary names of the active
moiety, carries the risk of serious adverse drug events by overdose.
From the Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology,
Stuttgart (Drs Schwab and Eichelbaum), Robert Bosch Hospital, Center of Internal
Medicine, Stuttgart (Dr Oetzel), and the Division of Clinical Pharmacology,
University Hospital Tübingen, Tübingen (Drs Mörike, Jägle,
Gleiter, and Eichelbaum), Germany.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Physician Use of Brand Versus Generic Drug Names in 1993-1994 and 2003-2004
Kwo et al.
The Annals of Pharmacotherapy 2009;43:459-468.
ABSTRACT
| FULL TEXT
News Media Coverage of Medication Research: Reporting Pharmaceutical Company Funding and Use of Generic Medication Names
Hochman et al.
JAMA 2008;300:1544-1550.
ABSTRACT
| FULL TEXT
Intraventricular Block and Atrioventricular Conduction
Spodick
Arch Intern Med 2002;162:2635-2636.
FULL TEXT
Using Trade Names: Sometimes It Helps
Anton et al.
Arch Intern Med 2002;162:2636-2636.
FULL TEXT
Trade Name, INNs, and Medication Errors
Cohen and Schwab
Arch Intern Med 2002;162:2636-2637.
FULL TEXT
|
